Pennington Biomedical Research Center today announced it is conducting its first vaccination trial, participating in testing the safety and effectiveness of Moderna’s COVID-19 vaccine for children under 12 in a phase three clinical trial.
Pennington Biomedical Research Center today announced it is conducting its first vaccination trial, participating in testing the safety and effectiveness of Moderna’s COVID-19 vaccine for children under 12 in a phase three clinical trial.